摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,4-Diacetoxy-1-phenyl-2-chinolon | 50899-88-2

中文名称
——
中文别名
——
英文名称
3,4-Diacetoxy-1-phenyl-2-chinolon
英文别名
(3-Acetyloxy-2-oxo-1-phenylquinolin-4-yl) acetate
3,4-Diacetoxy-1-phenyl-2-chinolon化学式
CAS
50899-88-2
化学式
C19H15NO5
mdl
——
分子量
337.332
InChiKey
OOJGSMYQRCEDTE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    25
  • 可旋转键数:
    5
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.11
  • 拓扑面积:
    72.9
  • 氢给体数:
    0
  • 氢受体数:
    5

文献信息

  • Quinolinone derivative and antiallergic agent with said quinolinone derivative as the active ingredient
    申请人:DAINIPPON INK AND CHEMICALS, INC.
    公开号:EP0785190A2
    公开(公告)日:1997-07-23
    The present invention offers 7-aminoquinolinone derivatives, physiologically acceptable salts thereof, anti-allergic agents having as an active ingredient a 7-aminoquinolinone derivative or physiologically acceptable salt thereof, and 7-nitroquinolinone derivatives, wherein the 7-aminoquinolinone derivative is expressed by the following general formula (I):    wherein R1 is a hydrogen atom or an alkyl group; R2 and R3 are mutually different groups, each of which is selected from among hydrogen atoms, acyl groups, alkyl groups or alkenyl groups; and R4 and R5 are mutually different or identical groups, each of which is selected from among hydrogen atoms, acyl groups, alkyl groups, alkenyl groups or aralkyl groups; and physiologically acceptable salts thereof.
    本发明提供了7-氨基喹啉生物、其生理学上可接受的盐、以7-氨基喹啉生物或其生理学上可接受的盐为活性成分的抗过敏剂,以及7-硝基喹啉生物,其中7-氨基喹啉生物由以下通式(I)表示: 其中 R1 是原子或烷基; R2 和 R3 是互不相同的基团,每个基团选自原子、酰基、烷基或基;以及 R4 和 R5 是相互不同或相同的基团,各自选自原子、酰基、烷基、基或芳烷基; 及其生理上可接受的盐类。
  • Quinolinone derivative, method for preparing the same, and anti-allergic agent
    申请人:DAINIPPON INK AND CHEMICALS, INC.
    公开号:EP0927718A1
    公开(公告)日:1999-07-07
    The present invention relates to a simple method for preparing a quinolinone derivative, which is effective as a medicine, e.g., as an agent for treating allergic diseases and the like; novel amide derivatives effective as an intermediate in the method; novel quinolinone derivatives obtained according to the method; and an anti-allergic agent contaiirng a quinolinone derivative and/or physiological salt of the same as the active ingredients. The quinolinone derivative is expressed by the following general formula (II); and the method is characterized in that an amide derivative, expressed by the following general formula (I), is reacted with a basic agent, followed by intramolecular ring formation:    General Formula (I)    [wherein, R1 represents a hydrogen atom, an alkyl group, an alkyl group containing a hydroxyl group, an alkenyl group, or an aryl group; R2 represents an alkyl group, an alkenyl group, an aryl group, or an aralkyl group; R3 represents a reactive carboxyl group; and R4 to R7 represent, respectively and independently, a hydrogen atom, a hydroxyl group, an alkyl group, an alkoxy group, an alkenyl group, an alkenyloxy group, an aryl group, an aryloxy group, an aralkyloxy group, a R8R9N group (wherein, R8 and R9 represent, respectively and independently, a hydrogen atom, an alkyl group, an aikenyl group, an aralkyl group, or an acyl group), a nitro group, or a R10OOC group (wherein, R10 represents a hydrogen atom, an alkyl group, an alkenyl group, an aryl group, or an aralkyl group)].    General Formula (II)    [wherein, R1, R2 and R4 to R7 represent, respectively, the same constituents as described in general formula (I)].
    本发明涉及一种制备喹啉生物的简便方法,该衍生物可有效地用作药物,如治疗过敏性疾病等的药物;在该方法中作为中间体有效的新型酰胺生物;根据该方法获得的新型喹啉生物;以及含有喹啉生物和/或其生理盐作为有效成分的抗过敏药物。喹啉生物由以下通式(II)表示;该方法的特征在于,由以下通式(I)表示的酰胺生物与碱性剂反应,然后进行分子内成环: 通式 (I) [其中,R1 代表原子、烷基、含羟基的烷基、基或芳基;R2 代表烷基、基、芳基或芳烷基;R3 代表活性羧基;以及 R4 至 R7 分别独立地代表原子、羟基、烷基、烷基、基、基、芳基、芳基、芳烷基、R8R9N 基团(其中,R8 和 R9 分别独立地代表原子、羟基、烷基、烷基、基、基、芳基、芳烷基、芳烷基)、分别独立地代表原子、烷基、基、芳基或酰基)、硝基或 R10OOC 基团(其中,R10 代表原子、烷基、基、芳基或芳基)]。 通式 (II) [其中,R1、R2 和 R4 至 R7 分别代表与通式 (I) 所述相同的成分]。
  • US5942521A
    申请人:——
    公开号:US5942521A
    公开(公告)日:1999-08-24
  • US6136822A
    申请人:——
    公开号:US6136822A
    公开(公告)日:2000-10-24
  • US6271416B1
    申请人:——
    公开号:US6271416B1
    公开(公告)日:2001-08-07
查看更多